Luoma, Adrienne M.
Harvard University · Dana-Farber Cancer Institute
9 papers on CoChatORCID 0000-0001-9504-2403
Most cited papers
- Verified
An immunogenic personal neoantigen vaccine for patients with melanoma
Ott, P. A., Hu, Z., Keskin, D. B., Shukla, S. A., Sun, J., Bozym, D. J., Zhang, W., Luoma, A., Giobbie-Hurder, A., Peter, L., et al. (2017) · Nature
Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers
Cited by 2,936
- Verified
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Jerby-Arnon, L., Shah, P., Cuoco, M. S., Rodman, C., Su, M.-J., Melms, J. C., Leeson, R., Kanodia, A., Mei, S., Lin, J.-R., et al. (2018) · Cell
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 1,429
- Verified
A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing
Pan, D., Kobayashi, A., Jiang, P., Ferrari de Andrade, L., Tay, R. E., Luoma, A. M., Tsoucas, D., Qiu, X., Lim, K., Rao, P., et al. (2018) · Science
Cancer Immunotherapy and BiomarkersChromatin Remodeling and Cancer
Cited by 852
- Verified
MHC-II neoantigens shape tumour immunity and response to immunotherapy
Alspach, E., Lussier, D. M., Miceli, A. P., Kizhvatov, I., DuPage, M., Luoma, A. M., Meng, W., Lichti, C. F., Esaulova, E., Vomund, A. N., et al. (2019) · Nature
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 846
- Verified
Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy
Luoma, A. M., Suo, S., Williams, H. L., Sharova, T., Sullivan, K., Manos, M., Bowling, P., Hodi, F. S., Rahma, O., Sullivan, R. J., et al. (2020) · Cell
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 484
- Verified
Understanding and treating the inflammatory adverse events of cancer immunotherapy
Dougan, M., Luoma, A. M., Dougan, S. K., & Wucherpfennig, K. W. (2021) · Cell
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 319
- Verified
Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion
Frangieh, C. J., Melms, J. C., Thakore, P. I., Geiger-Schuller, K. R., Ho, P., Luoma, A. M., Cleary, B., Jerby-Arnon, L., Malu, S., Cuoco, M. S., et al. (2021) · Nature Genetics
Cancer Immunotherapy and BiomarkersSingle-cell and spatial transcriptomics
Cited by 276
- Verified
SCAP is required for timely and proper myelin membrane synthesis
Verheijen, M. H. G., Camargo, N., Verdier, V., Nadra, K., de Preux Charles, A.-S., Médard, J.-J., Luoma, A., Crowther, M., Inouye, H., Shimano, H., et al. (2009) · Proceedings of the National Academy of Sciences
Lipid metabolism and biosynthesisCancer, Lipids, and Metabolism
Cited by 119
- Verified
Plasmalogen phospholipids protect internodal myelin from oxidative damage
Luoma, A. M., Kuo, F., Cakici, O., Crowther, M. N., Denninger, A. R., Avila, R. L., Brites, P., & Kirschner, D. A. (2015) · Free Radical Biology and Medicine
Antioxidant Activity and Oxidative StressRedox biology and oxidative stress
Cited by 97
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free